Article Text

Download PDFPDF
OC-079 Previous exposure to hepatitis b infection and liver outcomes in a population with hepatitis c
  1. R Swann1,
  2. H Wang2,
  3. E Thomas3,
  4. H Innes4,
  5. C Schnier4,
  6. S Hutchinson4,
  7. PR Mills1,
  8. J Dillon5
  9. and Scottish HCV Clinical database monitoring committee
  1. 1Department of Gastroenterology, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasgow
  2. 2Deaprtment of Epidemiology and Statistics, University of Dundee, Dundee
  3. 3Medical School, University of Glasgow
  4. 4Heath Protection Scotland, NHS Scotland, Glasgow
  5. 5Medical Research Institute, University of Dundee, Dundee, UK


Introduction Coinfection with HCV and HBV is associated with adverse liver outcomes.1While most patients who are acutely infected with HBV in adulthood will clear the virus, up to 80% continue to have evidence of persistent HBV DNA in their liver.2The clinical impact of previous HBV infection on liver outcomes in HCV infection is unknown. In the UK, HBV vaccination is only targeted at high risk groups and uptake of this is incomplete. Therefore assessing any additional risk of liver disease posed by previous HBV infection is of importance to public health policy.

We aimed to determine any association of previous HBV infection with adverse liver outcomes in a large Scottish cohort of HCV infected patients, using anti-HBV core antibody (Anti-HBc) positivity as a marker of previous exposure.

Method The Scottish HCV Clinical Database containing clinical data for all patients attending HCV clinics in participating health boards was linked to the HBV virology database and Information Services Division, Scotland data on mortality and hospital admission data. Duplicate patient records, those with no recorded positive HCV RNA and those with incomplete HBV status were excluded from the analysis. Univariate and multivariate cox regressional models and Accelerated Failure Time models were constructed for time to clinical diagnosis of cirrhosis and hepatocellular carcinoma. Models were fitted using both date of birth and date of diagnosis with last follow up or death used as censor date.

Results 9,573 patient records were included in the analysis (197 HBsAg positive, 1723 Anti-HBc positive, HBsAg negative, 7653 Anti-HBc negative). Previous HBV infection (Anti-HBc positive, HBsAg negative) was significantly associated with development of cirrhosis (HR 1.46, 1.29–1.65) and development of HCC (HR 1.67, 1.17–2.37) on multivariate analysis. These associations remained significant in all models fitted. Other factors associated with poorer outcome were alcohol excess, older age, male sex and genotype 3 HCV. Achieving SVR and IVDU were associated with lower risk of cirrhosis and HCC.

Conclusion This is the largest study to date to show an association between previous HBV infection and adverse liver outcomes in HCV infection. Our data complements a growing body of evidence which suggests HBV infection may have adverse effects on liver health despite apparent clearance. This has important implications for the UK HBV vaccination policy and requires further investigation.

Disclosure of interest None Declared.


  1. Zarski JP, Bohn B, Bastie A, et al. J Hepatol. 1998;28:27–33

  2. Sagnelli E, Imparato M, Coppola N, et al. J Med Virol. 2008;80:1547–1553

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.